Zelda Therapeutics Limited announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics). Subject to approval from Zelda shareholders, and all conditions of sale being met, Zelda is proposing to acquire 100% of Ilera Therapeutics through an all-scrip transaction. The merger between Zelda and Ilera Therapeutics will create a global medicinal cannabis company, which will be renamed Zelira Therapeutics Limited ("Zelira"). Current Zelda Directors, Mara Gordon and Dr. Stewart Washer will step-down from the Board once the merger has been approved.